Order Sets Software helps optimize patient outcomes.
Share:
Press Release Summary:
With cloud-based InOrder, clinicians can author, review, and publish orders in collaborative environment that translates evidence-based knowledge into better patient care. Program includes access to answers from ClinicalKey clinical insight engine; collaboration tools for order set development, maintenance, access, and tracking; and tailored, concise ordering focused on most common scenarios. By making updates as regulations and medications change, InOrder helps prevent medical errors.
Original Press Release:
Elsevier Launches Evidence-Based, Collaborative Order Sets Solution
PHILADELPHIA, --
InOrder is designed to improve patient outcomes and meaningful use attestation by providing intuitive authoring, superior usability and high quality content
Elsevier http://www.elsevier.com, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of InOrder http://www.clinicaldecisionsupport.com/inorder , an intuitive, cloud-based order sets solution that enables clinicians to author, review and publish orders in a collaborative environment that quickly translates evidence-based knowledge into better patient care.
"InOrder combines a highly efficient, easy-to-use content management workflow solution for hospitals' content development and technology teams, with hundreds of evidence-based, highly usable order sets that can be used 'out of the box' or customized as needed," said Dr. Jonathan Teich, Elsevier's Chief Medical Informatics Officer. "InOrder's localization feature allows users to create order sets from their hospital preferences by incorporating orderable items directly from their existing EHRs, including their current workflows and terminologies."
By combining Elsevier's deep experience in providing evidence-based content and the capability to make updates rapidly as regulations and medications change, InOrder can help hospitals and clinicians increase patient safety and prevent medical errors.
"Evidence-based order sets facilitate best practices in diagnosis and treatment, thereby enabling healthcare organizations to improve care quality, support standardization , and achieve meaningful use," said Nancy Fabozzi, Principal Analyst, Frost & Sullivan.
"Providers will value a well-designed, technology-enabled solution based on trusted content that leverages proprietary clinical systems, workflows, and terminologies that are designed to accelerate product implementation, integration, usability, and clinician acceptance."
Without integrated systems in place to support efficient order set creation and review, hospitals and health systems often can take months to create or update a single order set. Without understanding and streamlining the communications among multiple authors and approvers, insufficient order set systems can languish and fail despite the best efforts of the contributors.
"I strongly believe that an advanced order set solution can lead to improvements in patient care," said Carol Steltenkamp, Chief Medical Information Officer, University of Kentucky HealthCare, an InOrder beta customer. "We were eager to implement InOrder by Elsevier because it streamlines the entire process of creating, managing and maintaining order sets, and ensuring that all order sets are based on current evidence-based information and best practices."
InOrder includes:
- Access to relevant evidence-based answers from ClinicalKey, Elsevier's clinical insight engine
- Advanced collaboration tools for order set development, maintenance, access and tracking
- Tailored, concise ordering focused on the most common scenarios
- Availability across technology platforms enabled by a cloud-based delivery model
- Localization tools to incorporate hospitals' clinical terminologies and import existing order sets
- Enhanced clinical guidance and evidence within the set
- Quality metric indicators that highlight orders important for guidelines and metrics
"We developed InOrder with our customers top-of-mind and a goal of providing a superior solution that would positively impact patient care and support physician workflow," said Jay Katzen, president of Elsevier's clinical solutions business. "Our focus was on delivering a quality, metrics-driven system that was easy for clinicians to use. Clinicians will have the flexibility to manage their own workflow and order sets, access content that includes CDS guidance and regular updates, and utilize a layout based on the way they think and work."
For a demonstration of InOrder, and to learn more about Elsevier, visit them at
HIMSS13 http://www.himssconference.org (March 3-7) in New Orleans at booth #6129. A complete list of demonstrations and Elsevier presentations at HIMSS can be found be at http://www.clinicaldecisionsupport.com/himss13.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet http://www.thelancet.com and Cell http://www.cell.com , and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect http://www.sciencedirect.com, Scopus http://www.scopus.com , Reaxys http://www.reaxys.com, ClinicalKey https://www.clinicalkey.com and Mosby's Suite http://www.confidenceconnected.com, which enhance the productivity of science and health professionals, and the SciVal suite http://www.scival.com and MEDai's Pinpoint Review http://www.medai.com, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier http://www.elsevier.com employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC http://www.reedelsevier.com, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
CONTACT: Christopher Capot, Director, Corporate Relations, Elsevier, +1-212-633-3164, c.capot@elsevier.com
